In 2003, 19-year-old Stanford-dropout Elizabeth Holmes founded Theranos—a startup to make blood testing cheaper and more accessible. It is now 2015. The company is currently worth $9 million, and has collaborated with national supermarket and pharmacy chains Walgreens and Safeway. However, suspicions and rumours have been circulating: members of the press believe that Holmes is lying about her company’s technology. Moreover, The Wall Street Journal has an article ready to publish which seems to be critical of Theranos, and threatens to bring down its reputation.
Delegates will assume the role of top Silicon Valley executives, gathered to advise on how to proceed given updates about Theranos. How should Silicon Valley’s leaders deal with and react to this news? Is the technology really what Holmes claims it to be? Or is it something more sinister?
THERANOS
SINGLE CRISIS
DIRECTED BY: AMELIA HUI
theranos@ssicsim.ca